GGrantIndex
← Leaderboards

Rochelle P Walensky

Massachusetts General Hospital

$10,475,833
Attributed
$10,475,833
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $938.4K · FY200519
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$10,475,833 · 4

By mechanism

R01$6,071,160 · 2
R37$3,754,918 · 1
K23$649,755 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Prevent

Research focus

PreventInfectionCostDesignPoliciesBaseMedicineResearch PersonnelUnited States National Institutes Of HealthEvaluationCost EffectivenessAreaClinical Trials DesignBackAids Clinical Trial GroupEnvironmentAcquired Immunodeficiency SyndromeEnrollmentHiv DiagnosisCaringBudgetsComputer SimulationGoldClinical Trials

Grant awards (20)

Novel Methods to Inform HIV/TB Clinical Trial Development$745,684
R37 · FY2019 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$732,206
R37 · FY2018 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$745,409
R37 · FY2017 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$731,458
R37 · FY2016 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$800,161
R37 · FY2015 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$580,139
R01 · FY2014 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$358,268
R01 · FY2014 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$545,328
R01 · FY2013 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$580,325
R01 · FY2012 · AI · contact PI
Novel Methods to Inform HIV/TB Clinical Trial Development$664,504
R01 · FY2011 · AI · contact PI
Optimizing strategies for universal HIV testing$535,690
R01 · FY2010 · MH · contact PI
Optimizing strategies for universal HIV testing$700,368
R01 · FY2009 · MH · contact PI
Optimizing strategies for universal HIV testing$640,975
R01 · FY2008 · MH · contact PI
Optimizing strategies for universal HIV testing$811,825
R01 · FY2007 · MH · contact PI
Optimizing strategies for universal HIV testing$653,738
R01 · FY2006 · MH · contact PI
Treatment Models for Primary and Chronic HIV Infection$129,951
K23 · FY2005 · AI
Treatment Models for Primary and Chronic HIV Infection$129,951
K23 · FY2004 · AI
Treatment Models for Primary and Chronic HIV Infection$129,951
K23 · FY2003 · AI
Treatment Models for Primary and Chronic HIV Infection$129,951
K23 · FY2002 · AI
Treatment Models for Primary and Chronic HIV Infection$129,951
K23 · FY2001 · AI